Jump to content
RemedySpot.com

Re: EDITORIAL - Arthritis gene therapy trials reach Phase II

Rate this topic


Guest guest

Recommended Posts

Guest guest

I'd like to be hopeful, but I'm still creeped out by that death a few yrs back.

Kate f

Sent from my iPhone

On Apr 8, 2010, at 7:13 AM, <Rheumatoid.Arthritis.Support@...>

wrote:

Journal of Rheumatology

April 2010

Editorial

Arthritis Gene Therapy Trials Reach Phase II

Arthritis has been on the gene therapy agenda for about 20 years1.

Despite its impressive preclinical track record of efficacy and safety

in animal models (as reviewed5,6), progress in carrying out clinical

trials has been painfully slow4. The literature contains only 2 small

Phase I studies3,4 and a report of 2 subjects who experienced

symptomatic relief following gene transfer7. The Phase I/II trial

described by Mease, et al in this issue of The Journal8 is thus very

much to be welcomed. Not only does it greatly increase the number of

subjects who have received gene therapy for arthritis, but it is also

the first trial to address efficacy in a substantial fashion.

Although there are several different strategies for using genes as

therapeutic agents in arthritis, by far the most progress has been

made with the approach of delivering genes locally to individual

diseased joints2,3. There are a number of reasons for this. Not only

was it the first arthritis gene therapy strategy to be proposed1, but

also, by enabling sustained, endogenous, intraarticular synthesis of

therapeutic gene products in selected joints, local delivery achieves

something that no other technology can accomplish. Moreover,

expressing the gene product intraarticularly minimizes exposure of

non-target sites, thereby reducing the potential for unwanted side

effects. The smaller requirements of local, rather than systemic,

treatment also lower costs, especially as a successful gene therapy

will require infrequent redosing. The burden of treating multiple

joints individually in patients with rheumatoid arthritis (RA) may be

less than first thought, following the discovery that the genetic

treatment of just one joint in animals with polyarticular disease

secures improvement in additional joints on the same individual9. The

degree to which suppression of intraarticular disease mitigates

extraarticular manifestations of RA remains to be determined.

********************************************

Read the full editorial here:

http://jrheum.org/content/37/4/683.full

Not an MD

Link to comment
Share on other sites

Guest guest

Kate,

I am also still disturbed by that case. Not good.

Not an MD

On Thu, Apr 8, 2010 at 7:36 PM, Kate Fair <kalfoley@...> wrote:

> I'd like to be hopeful, but I'm still creeped out by that death a few yrs

back. Kate f

Link to comment
Share on other sites

Guest guest

What case?  Can anyone enlighten me?

 

TIA,

Sheryl

From: <Rheumatoid.Arthritis.Support@...>

Subject: Re: [ ] EDITORIAL - Arthritis gene therapy trials reach Phase

II

Date: Friday, April 9, 2010, 7:13 AM

 

Kate,

I am also still disturbed by that case. Not good.

Not an MD

Link to comment
Share on other sites

Guest guest

Sheryl,

Kate and I are talking about the unfortunate death of RA patient Jolee

Mohr in a gene therapy trial.

Here are some related articles:

http://www.wired.com/medtech/genetics/news/2007/08/gene_therapy

http://www.wired.com/wiredscience/2007/11/tests-clear-gen/

http://www.bioethics.net/articles.php?viewCat=2 & articleId=202

If you search on her name, you will find many more articles related to the case.

Not an MD

On Fri, Apr 9, 2010 at 9:40 AM, Sheryl <Arrow31298@...> wrote:

> What case?  Can anyone enlighten me?

>

> TIA,

>

>

> Sheryl

Link to comment
Share on other sites

Guest guest

Hi ,

 

Thanks for the links.  How tragic and scary.  :(

Sheryl

From: <Rheumatoid.Arthritis.Support@...>

Subject: Re: [ ] EDITORIAL - Arthritis gene therapy trials reach Phase

II

Date: Friday, April 9, 2010, 6:03 PM

 

Sheryl,

Kate and I are talking about the unfortunate death of RA patient Jolee

Mohr in a gene therapy trial.

Here are some related articles:

http://www.wired. com/medtech/ genetics/ news/2007/ 08/gene_therapy

http://www.wired. com/wiredscience /2007/11/ tests-clear- gen/

http://www.bioethic s.net/articles. php?viewCat= 2 & articleId= 202

If you search on her name, you will find many more articles related to the case.

Not an MD

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...